About Aurobindo Pharma Ltd.

Aurobindo Pharma Limited is a multinational pharmaceutical company based in Hyderabad, Telangana, India. The company manufactures and sells over 300 products in over 150 countries across the globe in 6 major therapeutic segments such as antibiotics, anti-retrovirals, CVS, CNS, gastroenterologicals and anti-allergics.

 

The company is among the top 10 companies in India in terms of consolidated revenues. In the fiscal year 2015, more than 86% of its revenues came from international operations, including sales to multinational companies.

 

As of 31st March 2015, Aurobindo Pharma had:

 

  • 19 manufacturing facilities (15 in India, and 3 in the US, and 1 in Brazil)
  • 3 R&D Centres employing over 650 scientists, including 35 PhDs
  • Invested 3.90% of gross annual revenues on R&D

About 50.5% of Aurobindo Pharma's sales during the fiscal year 2015 were to the United States, its largest market, 33.4% to Europe and 16.1% to emerging markets.

 

Future plans include:

 

  • 3 new plants in FY 2106
  • Doubling capacity of 3 more plants in FY 2016
  • Increase sales to US, Europe and Japan
  • Rx to OTC switch molecules, ANDA & Monograph OTC products in various dosage formats (solids, liquids, semi-solids & nasal sprays)
  • Foray into oncology and hormonal products, penems and peptides technology

 

Aurobindo Pharma is listed on Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE).

 

Aurobindo Pharma Ltd. at-a-glance

 

Employees

11,500

Approvals
USFDA, UKMHRA, WHO, TGA Australia, MCC-SA, ANVISA-Brazil, Health Canada, GCC DR, Japan PMDA

Turnover (year ended 31 March, 2015)

~ USD 2 billion

Markets Served

150+

Manufacturing Facilities

19

Regulatory Filings

2,588

Patents filed till date

594

*Source:
http://www.aurobindo.com/docs/annual-reports/Aurobindo_Annual_Report_2014_15.pdf

 

History of Aurobindo Pharma Ltd.

Aurobindo Pharma Limited started operations with a small Semi-Synthetic Penicillin (SSP) manufacturing unit in Pondicherry in 1988 and has grown to become a leading player in SSPs, non-penicillins, cephalosporins and non-cephalosporins.

 

It is among the top 10 companies in India in terms of consolidated revenues. In the fiscal year 2015, more than 86% of its revenues came from international sales, and 14% came from domestic sales.

 

The company plans to achieve USD 3 billion in revenues by 2017-18 – while retaining its global leadership in Semi-Synthetic Penicillin (SSP), cephalosporins, new anti-infectives and lifestyle disease drugs.

 

As of 31st March 2015, Aurobindo Pharma had:

 

  • Filed 376 ANDAs – out of which 166 were approved, 27 had tentative approval and 183 are under review for approval
  • Established capabilities in Contract Research and Manufacturing Services (CRAMS) and regularly supplies impurity standards to the United States Pharmacopeial Convention (USP)

 

Milestones

 

  • 1988 - Commences business with 1 Semi-Synthetic Penicillin (SSP) unit
  • 1992 - Starts exporting
  • 1995 - Launches IPO and lists shares in Indian stock exchanges
  • 2001 - Sets up first overseas manufacturing plant in China
  • 2002 - Begins production of Finished Dosages
  • 2003 - Files first ANDA in USA
  • 2004 - Receives first ANDA and approval from US FDA
  • 2012 - Receives award for outstanding export performance from Ministry of Commerce & Industry, Govt. of India

 

BOARD OF DIRECTORS

 

  • Founder: Mr. PV. Ramaprasad Reddy, Mr. K Nityananda Reddy and others
  • Non-Executive Chairman: Mr. K Ragunathan
  • Wholetime Director & Vice Chairman Mr. K Nityananda Reddy
  • Non-Executive Director Mr. PV Ramaprasad Reddy, Mr. P. Sarath Chandra Reddy
  • Managing Director: Mr. N Govindarajan
  • Wholetime Directors: Dr. M. Sivakumaran, Mr. M. Madan Mohan Reddy
  • Managing Director: Mr. M. Sitarama Murthy, Dr. D. Rajagopala Reddy, Dr. (Mrs.) Avnit Bimal Singh

 

CONTACTS

 

REGISTERED OFFICE

Aurobindo Pharma Limited
Plot no. 2, Maitrivihar
Ameerpet
Hyderabad - 500038
Telangana, India.
Phone: +91 (40) 6672 5000
Fax: +91 (40) 2374 1080 / +91 (40) 2374 6833
Email: info@aurobindo.com

CORPORATE OFFICE

Aurobindo Pharma Limited
Water Mark Building,
Plot No. 11, Survey no.9
Kondapur, Hitech City
Hyderabad - 500 084
Telangana, India.
Phone: +91 (40) 6672 5000
Fax: +91 (40) 2374 1080 / +91 (40) 2374 6833
Email: info@aurobindo.com

USA OFFICE

Aurobindo Pharma USA INC.
6, Wheeling Road
Dayton, NJ 08810
USA
Contact Person: Mr. Rajeev TL
Email: rajeevtl@aurobindousa.com

Comment!
 
 






* Indicates mandatory field.
Please wait while comments are being sent...